Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Vaccine

• Publication date

  2004-01-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2003.09.008PMID 14741144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of seizures after measles-mumps-rubella immunization.

  1991cited by this paper
• Workshop on neurologic complications of pertussis and pertussis vaccination.

  1990cited by this paper
• Factors prognostic of unprovoked seizures after febrile convulsions.

  1987cited by this paper
• Febrile convulsions in a national cohort followed up from birth. II--Medical history and intellectual ability at 5 years of age.

  1985cited by this paper
• Seizures following childhood immunizations: Hirtz DG, Nelson KB, Ellenberg JH J Pediatr 102:14–18 Jan 1983

  1983cited by this paper
• Seizures following childhood immunizations.

  1983cited by this paper
• Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic Seizures

  1981cited by this paper
• Predictors of epilepsy in children who have experienced febrile seizures.

  1976cited by this paper

• Accuracy of ICD and SNOMED search strategies for adverse events following COVID-19 vaccination: Analysis of hospital administrative data.

  2026cites this paper
• Establishing a Multicenter Active Adverse Events Following Immunization Sentinel Surveillance Network Across 22 Tertiary Care Hospitals in India: Protocol for a Prospective Observational Study

  2025cites this paper
• Digital severity scoring and viral metagenomics: A feasibility study on integrated diagnosis of pediatric influenza-like illness.

  2025cites this paper
• Epidemiology of Febrile Seizures During the Covid-19 Pandemic: A Canadian Immunization Monitoring Program–Active (IMPACT) Study

  2025cites this paper
• Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS)

  2024cites this paper
• A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)

  2023cites this paper
• Development of Interoperable Computable Phenotype Algorithms for Adverse Events of Special Interest to Be Used for Biologics Safety Surveillance: Validation Study

  2023influential citation
• Safety of COVID-19 Vaccination in US Children Ages 5-11 Years.

  2022cites this paper
• Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China

  2022cites this paper
• Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

  2022cites this paper
• Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe.

  2022cites this paper
• Defining Causality in Neurological & Neuropsychiatric COVID-19 Vaccine Complications: What Have We Learnt from Current and Previous Vaccination Campaigns?

  2021cites this paper
• Revaccination outcomes of children with vaccine proximate seizures.

  2021cites this paper
• Evaluation of Vaccine Safety After the First Public Sector Introduction of Typhoid Conjugate Vaccine—Navi Mumbai, India, 2018

  2021cites this paper
• Febrile Seizures and Measles-Containing Vaccines in China: A Self-Controlled Case Series Study

  2021cites this paper
• Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine

  2021cites this paper
• Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder

  2021cites this paper
• Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador.

  2021cites this paper
• Characterization of Adverse Events Following Childhood Immunizations in Pinar del Río, Cuba.

  2021cites this paper
• Farmacovigilancia de vacunas y su aplicación en Chile

  2020cites this paper
• Empfehlungen zum Vorgehen bei Auftreten ungewöhnlicher neurologischer Symptome in zeitlichem Zusammenhang mit Impfungen im Kindes- und Jugendalter

  2020cites this paper
• Developmental outcomes following vaccine-proximate febrile seizures in children

  2020cites this paper
• [Recommendations on the approach when unusual neurological symptoms occur in temporal association with vaccinations in childhood and adolescence].

  2020cites this paper
• Applying sequential surveillance methods that use regression adjustment or weighting to control confounding in a multisite, rare-event, distributed setting: Part 2 in-depth example of a reanalysis of the measles-mumps-rubella-varicella combination vaccine and seizure risk.

  2019cites this paper
• Postvaccination Febrile Seizure Severity and Outcome

  2019cites this paper
• Burgess Rosemary (Orcid ID: 0000-0002-2664-4395) Scheffer Ingrid (Orcid ID: 0000-0002-2311-2174) Berkovic Samuel (Orcid ID: 0000-0003-4580-841X) SCN1A variants in vaccine-related febrile seizures: a prospective study

  2019cites this paper
• Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

  2019cites this paper
• SCN1A Variants in vaccine‐related febrile seizures: A prospective study

  2019cites this paper
• Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

  2019cites this paper
• ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.

  2019cites this paper
• Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

  2019cites this paper
• Varicella and Herpes Zoster

  2018cites this paper
• Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016

  2018cites this paper
• Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu®) among adults in THIN database of electronic UK primary healthcare records

  2018cites this paper
• Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016.

  2018cites this paper
• The Clinician’s Vaccine Safety Resource Guide

  2018influential citation
• Do Vaccines Cause Seizures

  2018cites this paper
• Measles, Mumps and Rubell (MMR)

  2018cites this paper
• Tetanus, Diphtheria and Pertussis

  2018cites this paper
• Do Combination Vaccines or Simultaneous Vaccination Increase the Risk of Adverse Events

  2018cites this paper
• Active safety monitoring of measles-mumps-rubella vaccine in the National Immunisation Programme of Sri Lanka

  2017cites this paper
• Febrile Seizure Risk after Vaccination in Children One to Five Months of Age.

  2017cites this paper
• Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China

  2017cites this paper
• Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data

  2017cites this paper
• Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial.

  2016cites this paper
• Empfehlungen zum Vorgehen bei Auftreten ungewöhnlicher neurologischer Symptome in zeitlichem Zusammenhang mit Impfungen im Kindes- und Jugendalter

  2016cites this paper
• An observational study of febrile seizures: the importance of viral infection and immunization

  2016cites this paper
• Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study

  2016cites this paper
• The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.

  2015cites this paper
• Comparative safety evaluation of 7-valent and 13-valent pneumococcal vaccines in routine paediatric vaccinations in four Italian regions, 2009 to 2011.

  2015cites this paper
• Hypotonic-hyporesponsive episodes after the application of vaccines in Cuba during the period 2012-2013

  2015cites this paper
• The incidence of childhood and adolescent seizures in the UK from 1999 to 2011: A retrospective cohort study using the Clinical Practice Research Datalink.

  2015cites this paper
• Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.

  2015cites this paper
• Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: A systematic review and meta-analysis.

  2015cites this paper
• Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions

  2015cites this paper
• Vaccine vigilance in Canada: Is it as robust as it could be?

  2014cites this paper
• Awareness and Utilization of Reporting Pathways for Adverse Events Following Immunization: Online Survey Among Pediatricians in Russia and Germany

  2014cites this paper
• The weight of MMRV-related febrile convulsions among other clinical factors contributing to febrile convulsions in children.

  2014cites this paper
• Rapport annuel du Système canadien de surveillance des effets secondaires suivant l'immunisation (SCSESSI) pour les vaccins administrés en 2012

  2014cites this paper
• Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012.

  2014cites this paper
• Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG

  2014cites this paper
• Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.

  2013cites this paper
• Agreement between medical record and parent report for evaluation of childhood febrile seizures.

  2013influential citation
• Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern Italy

  2013cites this paper
• Vaccine Development and Safety

  2013cites this paper
• First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

  2013cites this paper
• Template protocol for clinical trials investigating vaccines--focus on safety elements.

  2013cites this paper
• Prevalence of SCN1A-Related Dravet Syndrome among Children Reported with Seizures following Vaccination: A Population-Based Ten-Year Cohort Study

  2013cites this paper
• Epilepsy and vaccinations: Italian guidelines

  2013cites this paper
• Identification of seizures among adults and children following influenza vaccination using health insurance claims data.

  2013cites this paper
• A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

  2012cites this paper
• Biologically plausible and evidence-based risk intervals in immunization safety research.

  2012cites this paper
• Safety reporting in developing country vaccine clinical trials-a systematic review.

  2012cites this paper
• Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

  2012cites this paper
• Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system.

  2012cites this paper
• Pooled analysis of safety data from pediatric Phase II RTS,S/AS malaria candidate vaccine trials

  2011cites this paper
• First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

  2011cites this paper
• Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms.

  2011cites this paper
• Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

  2011cites this paper
• Reporting Adverse Events: Basis for a Common Representation

  2011cites this paper
• A retrospective population‐based study on seizures related to childhood vaccination

  2011cites this paper
• Vigilancia de eventos adversos post vacunación y seguridad de programas de inmunización

  2011cites this paper
• Surveillance of adverse effects following vaccination and safety of immunization programs.

  2011cites this paper
• Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine

  2011cites this paper
• Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

  2011cites this paper
• Report on terminology mapping and AEFI/ADE definitions

  2011cites this paper
• Active Surveillance of Adverse Events Following Immunization Among Healthcare Workers Immunized With the Influenza Vaccine

  2011cites this paper
• Understanding the Role of Human Variation in Vaccine Adverse Events: The Clinical Immunization Safety Assessment Network

  2011cites this paper
• The Value of Standardized Case Definitions in Encephalitis Clinical Research

  2011cites this paper
• Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010.

  2010cites this paper
• Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.

  2010cites this paper
• Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2010cites this paper
• Onychomadesis and hand, foot and mouth disease--is there a connection?

  2010cites this paper
• Surveillance for adverse events after DTwP/Hib vaccination in Brazil: sensitivity and factors associated with reporting.

  2010cites this paper
• Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial

  2010cites this paper
• Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children

  2010cites this paper
• Predictive value of seizure ICD-9 codes for vaccine safety research.

  2009cites this paper
• Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.

  2009cites this paper
• Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children

  2009cites this paper
• A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon

  2009cites this paper